Brightsurf Science News & Current Events

May 31, 2009
Penn researchers discover genetic risk factor for testicular cancer
Researchers at the University of Pennsylvania School of Medicine have uncovered variation around two genes that are associated with an increased risk of testicular cancer, which is the most common cancer among young men -- it now affects seven out of 100,000 white men in the United States each year.

International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury
The International Serious Adverse Events Consortium announced today initial results from its research designed to discover genetic markers that may predict individuals at risk for serious drug induced liver injury.

Hebrew U. to launch biggest center in Israel for brain research
Israel's largest institute for brain research will be launched this week at the Hebrew University of Jerusalem.

To what extent can environmental pollutants and alcohol affect GI health?
New research quantifies the precise effects of environmental pollutants and alcohol intake on gastrointestinal (GI) health.

First live 'cloning' of faces challenges assumptions about human behavior
Computer scientists at the University of East Anglia have developed a new way of cloning facial expressions during live conversations to help us better understand what influences our behavior when we communicate with others.

New surgical technique shows promising results for patients with cervical cancer
A new surgical technique could allow surgeons to perform a radical hysterectomy in patients with early stage cervical cancer -- with fewer complications, reduced morbidity and a lower risk of local tumor recurrence than current surgical methods, according to an article published online first and in the July edition of the Lancet Oncology.

2-drug combination appears safe and active in metastatic kidney cancer
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial.

Scientists announce major global collaboration to create online 'macroscopic observatory' of Earth's biodiversity
An online information system for life on Earth, now under construction, will take its place alongside the world meteorology data network that pools information to predict the weather.

MicroRNAs grease the cell's circadian clockwork
In the June 1 issue of G&D, Dr. Ueli Schibler and colleagues reveal a role for the liver-specific microRNA, miR-122, in the circadian regulation of lipid metabolism.

Combined stem cell-gene therapy approach cures human genetic disease in vitro
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem cell technology.

Liver disease 'shrunk' by blood-pressure drug
Researchers at Newcastle University have shown that a blood-pressure medicine has reversed the effects of early stage liver failure in some patients.

ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week
The American Society for Gastrointestinal Endoscopy will honor important contributions to the field of endoscopy during the fifth annual ASGE Crystal Awards on Sunday, May 31.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.